Stay updated on Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial page.

Latest updates to the Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section now lists Oost-Vlaanderen and West-Vlaanderen for study recruitment, with a page revision marked as v3.3.3. The HHS Vulnerability Disclosure link and the older Oost-Vlaanderen/West-Vlaanderen Locations entries were removed.SummaryDifference0.3%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe Publications section was updated with clearer language about volunteer-provided publications and auto-filled PubMed entries, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check50 days agoChange DetectedThe government funding status notice at the bottom of the page has been removed. This change does not affect the study content or information about the trial.SummaryDifference0.4%

- Check64 days agoChange DetectedThe page shows a new mobile-style navigation panel and a 'New Screenshot' overlay, with no changes to the study details, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange Detected- Updated operating status notice due to funding lapse and guidance to official status pages. - Version bumped from v3.1.0 to v3.2.0.SummaryDifference4%

- Check100 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial page.